Riskpilot← Back to searchSign inGet full accessG&G MEDICARE ApS
APSActiveCVR 30235495Dannevirkevej 5Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 20071 employeeswww.gg-medicare.dk
Revenue 2024
DKK 1,9M
+11% vs 2023
EBITDA margin
21.0%
+2% vs 2023
Equity ratio
68.6%
Financial strength
Net profit 2024
DKK 318K
+2% vs 2023
| Revenue | DKK 1,9M | +11% |
| EBITDA | DKK 408K | +2% |
| Net profit | DKK 318K | +2% |
| Total assets | DKK 3,7M | +18% |
| Equity | DKK 2,5M | +14% |
| Employees | 1 | — |
Legal name
G&G MEDICARE ApS
CVR number
30235495
Legal form
Anpartsselskab
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
22. januar 2007
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 direktører i forening.
Company purpose
Selskabets formål er indkøb og videresalg af fodplejeprodukter til statsautoriserede fodterapeuter og fodplejere og dermed beslægtet virksomhed.
Address
Dannevirkevej 5
Phone
+4576200001
Email
Info@gg-medicare.dk
Website
www.gg-medicare.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.935 | 3.522 | 1.093 | 1.112 | 1.497 | 1.367 | 1.450 | 1.774 | 1.507 | 1.566 | 1.092 | 1.746 | 1.944 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -31 | 426 | 286 | 198 | 328 | 200 | 117 | 446 | 219 | 138 | -61 | 399 | 408 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -31 | 426 | 286 | 198 | 328 | 200 | 117 | 446 | 219 | 138 | -61 | 399 | 408 |
| Net financials | -21 | -30 | -14 | -5 | -4 | -5 | -5 | 0 | -4 | -7 | 1 | 2 | -1 |
| Profit before tax | -52 | 396 | 271 | 192 | 323 | 195 | 112 | 446 | 215 | 131 | -60 | 401 | 408 |
| Tax | -0 | 88 | 70 | 51 | 73 | 44 | 31 | 101 | 48 | 29 | -12 | 59 | 90 |
| Net profit | -52 | 308 | 201 | 141 | 251 | 152 | 81 | 345 | 166 | 102 | -48 | 311 | 318 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.064 | 1.252 | 1.546 | 1.515 | 1.917 | 1.915 | 2.081 | 2.472 | 3.211 | 3.346 | 2.616 | 3.111 | 3.660 |
| Equity | 182 | 490 | 691 | 832 | 1.083 | 1.235 | 1.316 | 1.661 | 1.827 | 1.930 | 1.882 | 2.193 | 2.511 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 883 | 762 | 855 | 683 | 834 | 680 | 765 | 811 | 1.383 | 1.416 | 734 | 918 | 1.149 |
| Total debt | 883 | 762 | 855 | 683 | 834 | 680 | 765 | 811 | 1.383 | 1.416 | 734 | 918 | 1.149 |
EBITDA margin
21.0%
This company
15.8%
Market median
+33% vs market
20122024
Equity ratio
68.6%
This company
38.2%
Market median
+80% vs market
20122024
Return on equity
12.6%
This company
18.4%
Market median
+32% vs market
20122024
Net profit margin
16.3%
This company
8.1%
Market median
+101% vs market
20122024
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20122024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JC | Audit | 2007 | — | — |
LG Management | Management | 2007 | — | — |
HT | Audit | 2010 | — | — |
SG Management | Management | 2007 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
G&G HOLDING ApS | Company | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
G&G HOLDING ApS
G&G MEDICARE ApS Board members of G&G MEDICARE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Conrad Halling Olesen | Audit | 0 companies |
| Leif Georg Rindal | Management | 0 companies |
| Henrik Tommy Christensen | Audit | 0 companies |
| Steen Georg Pedersen | Management | 0 companies |